Literature DB >> 21159538

Management of the hospitalized patient with Parkinson's disease: current state of the field and need for guidelines.

Michael J Aminoff1, Chad W Christine, Joseph H Friedman, Kelvin L Chou, Kelly E Lyons, Rajesh Pahwa, Bastian R Bloem, Sotirios A Parashos, Catherine C Price, Irene A Malaty, Robert Iansek, Ivan Bodis-Wollner, Oksana Suchowersky, Wolfgang H Oertel, Jorge Zamudio, Joyce Oberdorf, Peter Schmidt, Michael S Okun.   

Abstract

OBJECTIVE: To review the literature and to identify practice gaps in the management of the hospitalized Parkinson's disease (PD) patient.
BACKGROUND: Patients with PD are admitted to hospitals at higher rates, and frequently have longer hospital stays than the general population. Little is known about outpatient interventions that might reduce the need for hospitalization and also reduce hospital-related complications.
METHODS: A literature review was performed on PubMed about hospitalization and PD between 1970 and 2010. In addition, in press peer-reviewed papers or published abstracts known to the authors were included. Information was reviewed by a National Parkinson Foundation workgroup and a narrative review article was generated.
RESULTS: Motor disturbances in PD are believed to be a causal factor in the higher rates of admissions and complications. However, other conditions are commonly recorded as the primary reason for hospitalization including motor complications, reduced mobility, lack of compliance, inappropriate use of neuroleptics, falls, fractures, pneumonia, and other important medical problems. There are many relevant issues related to hospitalization in PD. Medications, dosages and specific dosage schedules are critical. Staff training regarding medications and medication management may help to avoid complications, particularly those related to reduced mobility, and aspiration pneumonia. Treatment of infections and a return to early mobility is also critical to management.
CONCLUSIONS: Educational programs, recommendations, and guidelines are needed to better train interdisciplinary teams in the management of the PD patient. These initiatives have the potential for both cost savings and improved outcomes from a preventative and a hospital management standpoint.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21159538      PMCID: PMC3070297          DOI: 10.1016/j.parkreldis.2010.11.009

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  81 in total

1.  Risk factors for hip fracture among elderly patients with Parkinson's disease.

Authors:  Y Sato; M Kaji; T Tsuru; K Oizumi
Journal:  J Neurol Sci       Date:  2001-01-01       Impact factor: 3.181

2.  Olanzapine and clozapine: comparative effects on motor function in hallucinating PD patients.

Authors:  C G Goetz; L M Blasucci; S Leurgans; E J Pappert
Journal:  Neurology       Date:  2000-09-26       Impact factor: 9.910

3.  Clozapine and risperidone treatment of psychosis in Parkinson's disease.

Authors:  T Ellis; M E Cudkowicz; P M Sexton; J H Growdon
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2000       Impact factor: 2.198

4.  Clinical course and cause of death in elderly patients with idiopathic Parkinson's disease.

Authors:  Xinde Wang; Guangfa You; Haibo Chen; Xiaojie Cai
Journal:  Chin Med J (Engl)       Date:  2002-09       Impact factor: 2.628

5.  Introduction of simple swallowing ability test for prevention of aspiration pneumonia in the elderly and investigation of factors of swallowing disorders.

Authors:  Yoshiko Miyazaki; Motoki Arakawa; Junko Kizu
Journal:  Yakugaku Zasshi       Date:  2002-01       Impact factor: 0.302

6.  Clozapine for the treatment of drug-induced psychosis in Parkinson's disease: results of the 12 week open label extension in the PSYCLOPS trial.

Authors:  S A Factor; J H Friedman; M C Lannon; D Oakes; K Bourgeois
Journal:  Mov Disord       Date:  2001-01       Impact factor: 10.338

7.  Predictors of mortality among nursing home residents with a diagnosis of Parkinson's disease.

Authors:  Hubert H Fernandez; Kate L Lapane
Journal:  Med Sci Monit       Date:  2002-04

8.  Medical services utilization and prognosis in Parkinson disease: a population-based study.

Authors:  Sotirios A Parashos; Demetrius M Maraganore; Peter C O'Brien; Walter A Rocca
Journal:  Mayo Clin Proc       Date:  2002-09       Impact factor: 7.616

9.  Nonmotor fluctuations in Parkinson's disease: frequent and disabling.

Authors:  Tatiana Witjas; E Kaphan; J P Azulay; O Blin; M Ceccaldi; J Pouget; M Poncet; A Ali Chérif
Journal:  Neurology       Date:  2002-08-13       Impact factor: 9.910

10.  Quetiapine versus clozapine: a preliminary report of comparative effects on dopaminergic psychosis in patients with Parkinson's disease.

Authors:  L Morgante; A Epifanio; E Spina; A E Di Rosa; M Zappia; G Basile; P La Spina; A Quattrone
Journal:  Neurol Sci       Date:  2002-09       Impact factor: 3.307

View more
  28 in total

1.  Healthcare Data Analytics for Parkinson's Disease Patients: A Study of Hospital Cost and Utilization in the United States.

Authors:  Sunanda Mukherjee; Huanmei Wu; Josette Jones
Journal:  AMIA Annu Symp Proc       Date:  2017-02-10

2.  Orthopedic Surgery and Post-Operative Cognitive Decline in Idiopathic Parkinson's Disease: Considerations from a Pilot Study.

Authors:  Catherine C Price; Shellie-Anne Levy; Jared Tanner; Cyndi Garvan; Jade Ward; Farheen Akbar; Dawn Bowers; Mark Rice; Michael Okun
Journal:  J Parkinsons Dis       Date:  2015       Impact factor: 5.568

3.  The Emerging Role of Biomarkers in Adaptive Modulation of Clinical Brain Stimulation.

Authors:  Kimberly B Hoang; Dennis A Turner
Journal:  Neurosurgery       Date:  2019-09-01       Impact factor: 4.654

4.  Common neurodegenerative disorders in the perioperative setting: Recommendations for screening from the Society for Perioperative Assessment and Quality Improvement (SPAQI).

Authors:  Margaret Wiggins; Franchesca Arias; Richard D Urman; Deborah C Richman; Bobbie Jean Sweitzer; Angela F Edwards; Melissa J Armstrong; Anita Chopra; David J Libon; Catherine Price
Journal:  Perioper Care Oper Room Manag       Date:  2020-02-05

5.  Interdisciplinary palliative care for people with advanced Parkinson's disease: a view from the home.

Authors:  Jori E Fleisher; Ellen C Klostermann; Serena P Hess; Jeanette Lee; Erica Myrick; Joshua Chodosh
Journal:  Ann Palliat Med       Date:  2019-10-14

6.  Relative mortality in U.S. Medicare beneficiaries with Parkinson disease and hip and pelvic fractures.

Authors:  Marcie Harris-Hayes; Allison W Willis; Sandra E Klein; Sylvia Czuppon; Beth Crowner; Brad A Racette
Journal:  J Bone Joint Surg Am       Date:  2014-02-19       Impact factor: 5.284

Review 7.  Moving Parkinson care to the home.

Authors:  E Ray Dorsey; Floris P Vlaanderen; Lucien Jlpg Engelen; Karl Kieburtz; William Zhu; Kevin M Biglan; Marjan J Faber; Bastiaan R Bloem
Journal:  Mov Disord       Date:  2016-08-08       Impact factor: 10.338

8.  Effects of 6-hydroxydopamine exposure on motor activity and biochemical expression in zebrafish (Danio rerio) larvae.

Authors:  Chien-Wei Feng; Zhi-Hong Wen; Shi-Ying Huang; Han-Chun Hung; Chun-Hong Chen; San-Nan Yang; Nan-Fu Chen; Hui-Min Wang; Chung-Der Hsiao; Wu-Fu Chen
Journal:  Zebrafish       Date:  2014-04-10       Impact factor: 1.985

9.  Inpatient management of Parkinson disease: current challenges and future directions.

Authors:  Odinachi Oguh; Aleksandar Videnovic
Journal:  Neurohospitalist       Date:  2012-01

Review 10.  Early identification and treatment of communication and swallowing deficits in Parkinson disease.

Authors:  Michelle R Ciucci; Laura M Grant; Eunice S Paul Rajamanickam; Breanna L Hilby; Katherine V Blue; Corinne A Jones; Cynthia A Kelm-Nelson
Journal:  Semin Speech Lang       Date:  2013-10-28       Impact factor: 1.761

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.